Guanfacine and guanfacine extended release: Treatment for ADHD and related disorders

CNS Drug Reviews

Volumn 13, Issue 4, 2007, Pages 465-474

  Posey, David J ^a,b   McDougle, Christopher J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

ADHD; Attention deficit hyperactivity disorder; Guanfacine; Pervasive developmental disorder; Tourette's disorder

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CENTRAL STIMULANT AGENT; CLONIDINE; DEXAMPHETAMINE; GUANFACINE; METHYLPHENIDATE; MIRTAZAPINE; PHENOBARBITAL; PSYCHOTROPIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ANOREXIA; ATTENTION DEFICIT DISORDER; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR MALFORMATION; CLINICAL TRIAL; CONSTIPATION; DEVELOPMENTAL DISORDER; DIARRHEA; DIZZINESS; DRUG ABSORPTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG USE; ECG ABNORMALITY; FOOD AND DRUG ADMINISTRATION; HALF LIFE TIME; HEADACHE; HEART RATE; HEART RATE AND RHYTHM; HUMAN; HYPOTENSION; INSOMNIA; NONHUMAN; ORTHOSTATIC HYPOTENSION; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; SYNCOPE; UPPER ABDOMINAL PAIN; WEIGHT GAIN; XEROSTOMIA;

ADRENERGIC ALPHA-AGONISTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; DRUG DELIVERY SYSTEMS; GUANFACINE; HUMANS;

EID: 36849055135     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.2007.00026.x     Document Type: Review

References (45)

1. Abo-Zena RA, Bobek MB, Dweik RA (2000) Hypertensive urgency induced by an interaction of mirtazapine and clonidine. Pharmacotherapy 20 : 76 78.
2. Aman MG, Singh NN, Stewart AW, Field CJ (1985) The aberrant behavior checklist: A behavior rating scale of the assessment of treatment effects. Am J Ment Deficiency 89 : 485 491.
3. 2 receptor subtypes. J Neuroscience 11 : 4287 4298.
4. Arnsten AF, Li BM (2005) Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57 : 1377 1184.
5. Bailey RR, Neale TJ (1976) Rapid clonidine withdrawal with blood pressure overshoot exaggerated by beta-blockade. Br Med J 1 : 942 943.
6. 2-agonist inducer of growth hormone secretion - a comparison with clonidine. Psychoneuroendocrinology 18 : 45 55.
7. Biederman J, Melmed R, Patel A, McBurnett K, Donahue J, Lyne A (2007a) A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Poster presented at the American Psychiatric Association Annual Meeting, San Diego, CA.
8. Biederman J, Melmed R, Patel A, McBurnett K, Donahue J, Lyne A (2007b) Long-term, open-label study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Poster presented at the American Psychiatric Association Annual Meeting, San Diego, CA.
9. Boellner SW, Pennick M, Shojaei A, Fiske K (2006) Pharmacokinetics of guanfacine extended release in children and adolescents with ADHD. Poster presented at the U.S. Psychiatric & Mental Health Congress, New Orleans, LA.
10. Bream JB, Lauener H, Picard CW, Scholtysik G, White TG (1975) Substituted phenyl-acetyl guanidine: A new class of antihypertensive agents. Arzeimittelforschung 25 : 1477 1482.
11. Brozoski T, Brown RM, Rosvold HE, Goldman PS (1979) Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 2005 929 31.
12. Buckley M, Feely J (1991) Antagonism of antihypertensive effect of guanfacine by tricyclic antidepressants. Lancet 337 : 1173 1174.
13. Campbell M, Fish B, David R, Shapiro T, Collins P, Koh C (1972) Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children. J Autism Child Schizophr 2 : 343 358.
14. Campbell M, Small A, Collins P, Friedman E, David R, Genieser N (1976) Levodopa and levoamphetamine: A crossover study in young schizophrenic children. Curr Therap Res 19 : 70 86.
15. Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz R, Arnsten A, Leckman JF, Cohen DJ (1995) Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: Preliminary clinical experience. J Am Acad Child Adolesc Psych 34 : 1140 146
16. Connor DF, Fletcher KE, Swanson JM (1999) A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 38 : 1551 1559.
17. Doxey JC (1979) Pre- and postsynaptic effects of alpha-agonists in the anococcygeus muscle of the pithed rat. Eur J Pharmacol 54 : 185 189.
18. Dulcan M (1997) Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36 : 85S 121S.
19. DuPaul GJ, Anastopoulos AD, MacGoey KE, Power TJ, Reid R, Ikeda MJ (1998) Teacher ratings of attention-deficit/hyperactivity disorder symptoms: Factor structure and normative data. Psychol Assess 9 : 436 444.
20. Easton N, Shah YB, Marshall FH, Fone KC, Marsden CA (2006) Guanfacine produces differential effects in the frontal cortex compared with striatum: Assessed by phMRI BOLD contrast. Psychopharmacology 189 : 369 85.
21. Goyette CH, Conners CK, Ulrich RF (1978) Normative data on revised Conners parent and teacher rating scales. J Abnorm Child Psychol 6 : 221 236.
22. Gutgesell H, Atkins D, Barst R, Buck M, Franklin W, Humes R, Ringel R, Shaddy R, Taubert K (1999) Cardiovascular monitoring of children and adolescents receiving psychotropic drugs. Circulation 99 : 979 982.
23. Hazell PL, Stuart JE (2003) A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. J Am Acad Child Adolesc Psychiatry 42 : 886 894.
24. Horrigan JP, Barnhill LJ (1999) Guanfacine and secondary mania in children. J Affect Disord 54 : 309 314.
25. Hunt RD, Minderaa RB, Cohen DJ (1985) Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Psychiatry 24 : 617 629.
26. Hunt RD, Arnsten AF, Asbell MD (1995) An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34 : 50 54.
27. Fankhauser MP, Karumanchi VC, German ML, Yates A (1992) A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. J Clin Psychiatry 53 : 77 82.
28. Jaselskis CA, Cook EH, Jr., Fletcher KE, Leventhal BL (1992) Clonidine treatment of hyperactive and impulsive children with autistic disorder. J Clin Psychopharmacol 12 : 322 327.
29. Kiechel JR (1986) Pharmacokinetics of guanfacine in patients with impaired renal function and in some elderly patients. Am J Cardiol 57 : 18E 21E.
30. Lecavalier L (2006) Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification. J Autism Dev Disord 36 : 1101 1114.
31. Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ (1991) Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 48 : 324 328.
32. Luna B, Minshew NJ, Garver KE, Lazar NA, Thulborn KR, Eddy WF, Sweeney JA (2002) Neocortical system abnormalities in autism: An fMRI study of spatial working memory. Neurology 59 : 834 840.
33. Murphy DGM, Critchley HD, Schmitz N, McAlonan G, van Amelsvoort T, Robertson D, Daly E, Rowe A, Russell A, Simmons A, Murphy KC, Howlin P (2002) Asperger syndrome: A proton magnetic resonance spectroscopy study of brain. Arch Gen Psychiatry 59 : 885 891.
34. Ozonoff S, Cook I, Coon H, Dawson G, Joseph RM, Klin A, McMahon WM, Minshew N, Munson JA, Pennington BF, et al. (2004) Performance on Cambridge neuropsychological test automated battery subtests sensitive to frontal lobe function in people with autistic disorder: Evidence from the Collaborative Programs of Excellence in Autism Network. J Autism Dev Disord 34 : 139 150.
35. Posey DJ, Puntney JI, Sasher TM, Kem DL, McDougle CJ (2004) Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: A retrospective analysis of 80 cases. J Child Adolesc Psychopharmacol 14 : 233 241.
36. Research Units on Pediatric Psychopharmacology Autism Network (2005) Randomized controlled crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 62 : 1266 1274.
37. Sagvolden T (2006) The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of attention deficit/hyperactivity disorder (ADHD). Behav Brain Funct 2 : 41.
38. Sallee FR, McGough JJ, Wigal T, Donahue J, Lyne A, Biederman J (2007a) Randomized, double-blind study of guanfacine extended release in children aged 6 to 17 years with attention-deficit/hyperactivity disorder (ADHD). Poster presented at the American Psychiatric Association Annual Meeting, San Diego, CA.
39. Sallee FR, McGough JJ, Wigal T, Donahue J, Lyne A, Biederman J (2007b) Interim results of a long-term, open-label study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Poster presented at the American Psychiatric Association Annual Meeting, San Diego, CA.
40. Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, Arnsten AF, Cohen DJ, Leckman JF (2001) A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158 : 1067 1074.
41. Scahill L, Aman MG, McDougle CJ, McCracken JT, Tierney E, Dziura J, Arnold LE, Posey D, Young C, Shah B, et al. (2006) A prospective open trial of guanfacine in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol 16 : 589 598.
42. Shojaei AH, Chang R, Pennick M (2006) Guanfacine extended release tablets as treatment for attention-deficit/hyperactivity disorder: Formulation characteristics. Poster presented at the U.S. Psychiatric & Mental Health Congress, New Orleans, LA.
43. 2 adren-ergic agonist, guanfacine, on rCBF in human cortex in normal controls and subjects with focal epilepsy. Neuropsychopharmacology 23 : 263 275.
44. Taylor FB, Russo J (2001) Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 21 : 223 228.
45. Westfall TC, Westfall DP (2006) Adrenergic agonists and antagonists. In : Goodman & Gilman's the Pharmacological Basis of Therapeutics New York : McGraw-Hill, ch.10.